179 related articles for article (PubMed ID: 36930136)
1. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
Haring B; Hunt RP; Shadyab AH; Eaton C; Kaplan R; Martin LW; Panjrath G; Kuller LH; Assimes T; Kooperberg C; Wassertheil-Smoller S
JACC Heart Fail; 2023 Sep; 11(9):1189-1199. PubMed ID: 36930136
[TBL] [Abstract][Full Text] [Related]
2. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
[TBL] [Abstract][Full Text] [Related]
3. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
Kozlitina J; Garg S; Drazner MH; Matulevicius SA; Ayers C; Overton J; Reid J; Baras A; Rao K; Pandey A; Berry J; de Lemos JA; Grodin JL
J Card Fail; 2022 Mar; 28(3):403-414. PubMed ID: 34634447
[TBL] [Abstract][Full Text] [Related]
5. The amyloidogenic V122I transthyretin variant in elderly black Americans.
Quarta CC; Buxbaum JN; Shah AM; Falk RH; Claggett B; Kitzman DW; Mosley TH; Butler KR; Boerwinkle E; Solomon SD
N Engl J Med; 2015 Jan; 372(1):21-9. PubMed ID: 25551524
[TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
Agbor-Etang BB; Okafor HE; Farber-Eger EH; Wells QS
Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
[TBL] [Abstract][Full Text] [Related]
7. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US.
Selvaraj S; Claggett BL; Quarta CC; Yu B; Inciardi RM; Buxbaum JN; Mosley TH; Shah AM; Dorbala S; Falk RH; Solomon SD
JAMA Cardiol; 2023 Aug; 8(8):784-788. PubMed ID: 37212191
[TBL] [Abstract][Full Text] [Related]
8. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
Parker MM; Damrauer SM; Tcheandjieu C; Erbe D; Aldinc E; Hawkins PN; Gillmore JD; Hull LE; Lynch JA; Joseph J; Ticau S; Flynn-Carroll AO; Deaton AM; Ward LD; Assimes TL; Tsao PS; Chang KM; Rader DJ; Fitzgerald K; Vaishnaw AK; Hinkle G; Nioi P
Sci Rep; 2021 Jun; 11(1):11645. PubMed ID: 34079032
[TBL] [Abstract][Full Text] [Related]
9. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
Madhani A; Sabogal N; Massillon D; Paul LD; Rodriguez C; Fine D; Helmke S; Winburn M; Kurian D; Raiszadeh F; Teruya S; Cohn E; Einstein AJ; Miller EJ; Connors LH; Maurer MS; Ruberg FL
J Am Heart Assoc; 2023 Aug; 12(15):e028973. PubMed ID: 37486082
[TBL] [Abstract][Full Text] [Related]
10. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
Buxbaum J; Alexander A; Koziol J; Tagoe C; Fox E; Kitzman D
Am Heart J; 2010 May; 159(5):864-70. PubMed ID: 20435197
[TBL] [Abstract][Full Text] [Related]
11. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis.
Prokaeva T; Klimtchuk ES; Feschenko P; Spencer B; Cui H; Burks EJ; Aslebagh R; Muneeruddin K; Shaffer SA; Varghese E; Berk JL; Connors LH
Amyloid; 2023 Jun; 30(2):141-152. PubMed ID: 36286264
[TBL] [Abstract][Full Text] [Related]
12. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Buxbaum JN; Ruberg FL
Genet Med; 2017 Jul; 19(7):733-742. PubMed ID: 28102864
[TBL] [Abstract][Full Text] [Related]
14. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
Jacobson D; Tagoe C; Schwartzbard A; Shah A; Koziol J; Buxbaum J
Am J Cardiol; 2011 Aug; 108(3):440-4. PubMed ID: 21600538
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans.
Jacobson DR; Alexander AA; Tagoe C; Buxbaum JN
Amyloid; 2015; 22(3):171-4. PubMed ID: 26123279
[TBL] [Abstract][Full Text] [Related]
16. Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Sinha A; Zheng Y; Nannini D; Qu Y; Hou L; Shah SJ; Yancy CW; McNally EM; Fornage M; Lima J; Lloyd-Jones DM; Rasmussen-Torvik LJ; Khan SS
JAMA Cardiol; 2020 Dec; 6(6):1-5. PubMed ID: 33355618
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review.
Goyal A; Lahan S; Dalia T; Ranka S; Bhattad VB; Patel RR; Shah Z
Heart Fail Rev; 2022 May; 27(3):849-856. PubMed ID: 33768376
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
20. Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I
Hendren NS; De Lemos JA; Berry JD; Kozlitina J; Saelices L; Ji AX; Shao Z; Liu CF; Garg S; Farr MA; Drazner MH; Tang WHW; Grodin JL
Amyloid; 2024 Mar; ():1-8. PubMed ID: 38445629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
